Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 14, 2014; 20(30): 10518-10524
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10518
Table 5 Survival related factors in advanced gastric cancer
Clinicopathologic factorsUnivariable analysis for OS (P value, HR)Multivariable analysis for OS (P value, HR)Univariable analysis for RFS (P value, HR)Multivariable analysis for RFS (P value, HR)
Sex0.449, 1.1130.306, 1.150
Age0.025, 1.0130.001, 1.0200.470, 0.996
Size of the tumor< 0.001, 1.1390.127, 1.046< 0.001, 1.1770.012, 1.081
Operation method0.029, 1.3610.145, 0.7270.004, 1.4740.091, 0.697
Lymphatic invasion< 0.001, 3.5370.696, 1.094< 0.001, 3.0820.975, 0.993
Vascular invasion< 0.001, 2.8760.026, 1.428< 0.001, 2.8680.094, 1.313
Perineural invasion< 0.001, 2.4400.343, 1.189< 0.001, 2.3420.634, 1.092
Borrmann type< 0.0010.087< 0.0010.05
WHO Classification0.025, 1.3890.856, 1.0300.003, 1.5370.169, 1.745
Lauren Classification0.099, 1.2810.004, 1.5300.165, 0.572
Harvested lymph node0.191, 1.0040.288, 1.003
Positive lymph node< 0.001, 1.0480.001, 1.021< 0.001, 1.047< 0.001, 1.021
PM0.278, 0.9700.207, 0.966
DM0.047, 0.9690.660, 1.0090.035, 0.9680.670, 1.009
Stage< 0.001< 0.001< 0.001< 0.001